Magellan Rx — Magellan Rx Management is pleased to present the sixth edition of our Medical Pharmacy Trend Report,™ the only detailed source for current medical benefit drug management approaches and data benchmarking. Approximately 50 percent of the $124 billion annual specialty drug spend is billed on the medical benefit, yet visibility into this spend generally has been limited and benchmarks have not been broadly reported or discussed. As specialty drug costs continue to be a leading driver of overall drug trends, it is critical for payors to stay current with the evolving management strategies and marketplace conditions impacting medical pharmacy utilization and spend.